1. Home
  2. JAGX vs SXTC Comparison

JAGX vs SXTC Comparison

Compare JAGX & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jaguar Health Inc.

JAGX

Jaguar Health Inc.

HOLD

Current Price

$2.81

Market Cap

2.2M

Sector

Health Care

ML Signal

HOLD

Logo China SXT Pharmaceuticals Inc.

SXTC

China SXT Pharmaceuticals Inc.

HOLD

Current Price

$2.45

Market Cap

1.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JAGX
SXTC
Founded
2013
2005
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2M
1.8M
IPO Year
2014
2017

Fundamental Metrics

Financial Performance
Metric
JAGX
SXTC
Price
$2.81
$2.45
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$60.00
N/A
AVG Volume (30 Days)
62.4K
127.2K
Earning Date
04-07-2026
08-19-2019
Dividend Yield
N/A
N/A
EPS Growth
82.42
N/A
EPS
N/A
N/A
Revenue
$11,511,000.00
N/A
Revenue This Year
$61.58
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$0.03
52 Week High
$8.00
$6.98

Technical Indicators

Market Signals
Indicator
JAGX
SXTC
Relative Strength Index (RSI) 50.55 58.87
Support Level $1.76 $1.35
Resistance Level $4.13 $2.68
Average True Range (ATR) 0.27 0.34
MACD 0.03 0.00
Stochastic Oscillator 72.63 53.94

Price Performance

Historical Comparison
JAGX
SXTC

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

About SXTC China SXT Pharmaceuticals Inc.

China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.

Share on Social Networks: